The effect of valproic acid on drug and steroid glucuronidation by expressed human UDP-glucuronosyltransferasesETHELL, Brian T; ANDERSON, Gail D; BURCHELL, Brian et al.Biochemical pharmacology. 2003, Vol 65, Num 9, pp 1441-1449, issn 0006-2952, 9 p.Article

Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brainMIKSYS, Sharon; LERMAN, Caryn; SHIELDS, Peter G et al.Neuropharmacology. 2003, Vol 45, Num 1, pp 122-132, issn 0028-3908, 11 p.Article

In vivo activation of the human CYP3A4 promoter in mouse liver and regulation by pregnane X receptorsWEISHENG ZHANG; PURCHIO, Anthony; CHEN, Kevin et al.Biochemical pharmacology. 2003, Vol 65, Num 11, pp 1889-1896, issn 0006-2952, 8 p.Article

Biomimetic in vitro oxidation of lapachol: A model to predict and analyse the in vivo phase I metabolism of bioactive compoundsNIEHUES, Michael; PRISCILA BARROS, Valeria; DA SILVA EMERY, Flávio et al.European journal of medicinal chemistry. 2012, Vol 54, pp 804-812, issn 0223-5234, 9 p.Article

The impact of carbon—hydrogen bond dissociation energies on the prediction of the cytochrome P450 mediated major metabolic site of drug-like compoundsDREW, Kurt L. M; REYNISSON, Johannes.European journal of medicinal chemistry. 2012, Vol 56, pp 48-55, issn 0223-5234, 8 p.Article

SRC-3 is required for CAR-regulated hepatocyte proliferation and drug metabolismTENGHUI CHEN; QIANG CHEN; YIXIANG XU et al.Journal of hepatology. 2012, Vol 56, Num 1, pp 210-217, issn 0168-8278, 8 p.Article

The influence of in vitro procedures which diminish NADPH cytochrome c reductase activity on oxidative drug metabolism in lung and liver microsomesPARANDOOSH, Z; FRANKLIN, M. R.Biochimica et biophysica acta. 1983, Vol 760, Num 3, pp 327-334, issn 0006-3002Article

Effect of manganese on hepatic drug metabolism in male and female ratsCRAIG SCHNELL, R; DEIMLING, M. J.Research communications in chemical pathology and pharmacology. 1984, Vol 43, Num 2, pp 307-315, issn 0034-5164Article

The pharmacogenetics of drug metabolizing enzymes in the Lebanese populationOSSAILY, Safaa; ZGHEIB, Nathalie K.Drug metabolism and drug interactions. 2014, Vol 29, Num 2, pp 81-90, issn 0792-5077, 10 p.Article

Lisosan G, a powder of grain, does not interfer with the drug metabolizing enzymes and has a protective role on carbon tetrachloride-induced hepatotoxicityLONGO, Vincenzo; CHIRULLI, Vera; GIOVANNI GERVASI, Pier et al.Biotechnology letters. 2007, Vol 29, Num 8, pp 1155-1159, issn 0141-5492, 5 p.Article

Introduction to Hepatic Drug Metabolizing Enzyme Induction in Drug Safety Evaluation StudiesBOTTS, Suzanne; ENNULAT, Daniela; FRANCKE-CARROLL, Sabine et al.Toxicologic pathology. 2010, Vol 38, Num 5, pp 796-798, issn 0192-6233, 3 p.Article

Bioactivation of the heterocyclic aromatic amine 2-amino-3-methyl-9H-pyrido [2,3-b]indole (MeAaC) in recombinant test systems expressing human xenobiotic-metabolizing enzymesGLATT, Hansruedi; PABEL, Ulrike; MEINL, Walter et al.Carcinogenesis (New York. Print). 2004, Vol 25, Num 5, pp 801-807, issn 0143-3334, 7 p.Article

Mechanisms of inhibition of xenobiotic-metabolizing enzymesTESTA, B.Xenobiotica (London. Print). 1990, Vol 20, Num 11, pp 1129-1137, issn 0049-8254, 9 p.Conference Paper

Determination of phenol sulphotransferase activity by high-performance liquid chromatographyHONKASALO, T; NISSINEN, E.Journal of chromatography. 1988, Vol 424, Num 1, pp 136-140, issn 0021-9673Article

Liver cells and drugs, Rennes, July 7-10, 1987 = Cellules hépatiques et médicamentsGuillouzo, André.Colloques INSERM. 1988, issn 0768-3154, isbn 0-86196-128-5, XIX-494 p, isbn 0-86196-128-5Conference Proceedings

Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the cocktail approachFUHR, U; JETTER, A; KIRCHHEINER, J et al.Clinical pharmacology and therapeutics. 2007, Vol 81, Num 2, pp 270-283, issn 0009-9236, 14 p.Article

Genotyping for polymorphic drug metabolizing enzymes from paraffin-embedded and immunohistochemically stained tumor samplesRAE, James M; CORDERO, Kevin E; SCHEYS, Joshua O et al.Pharmacogenetics (London). 2003, Vol 13, Num 8, pp 501-507, issn 0960-314X, 7 p.Article

Sulfotransferase in humans: development and tissue distributionPACIFICI, G. M; FRANCHI, M; COLIZZI, C et al.Pharmacology. 1988, Vol 36, Num 6, pp 411-419, issn 0031-7012Article

My warm memories of James R. GilletteKATO, Ryuichi.Drug metabolism and disposition. 2003, Vol 31, Num 12, pp 1474-1475, issn 0090-9556, 2 p.Article

Role of the red blood cell in drug metabolismCOSSUM, P. A.Biopharmaceutics & drug disposition. 1988, Vol 9, Num 4, pp 321-336, issn 0142-2782Article

British Pharmacological Society. Clinical Pharmacology Section. MeetingBritish journal of clinical pharmacology. 1993, Vol 36, Num 2, pp 139-182, issn 0306-5251Conference Proceedings

A-Esterases: enzymes looking for a role?MACKNESS, M. I.Biochemical pharmacology. 1989, Vol 38, Num 3, pp 385-390, issn 0006-2952Article

Cimetidine interaction with liver microsomes in vitro and in vivo: involvement of an activated complex with cytochrome P-450CHRIS JENSEN, J; GUGLER, R.Biochemical pharmacology. 1985, Vol 34, Num 12, pp 2141-2146, issn 0006-2952Article

Human pharmacogeneticsWEINSHILBOUM, R. M.Federation proceedings. 1984, Vol 43, Num 8, pp 2295-2318, issn 0014-9446Article

Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphismWEDLUND, P. J; ASLANIAN, W. S; MACALLISTER, C. B et al.Clinical pharmacology and therapeutics. 1984, Vol 36, Num 6, pp 773-780, issn 0009-9236Article